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Optimization of nanoemulsion containing gemcitabine and evaluation of its cytotoxicity 
towards human fetal lung fibroblast (MRC5) and human lung carcinoma (A549) cells 
 
ABSTRACT 
Background: Gemcitabine (GEM) is a chemotherapeutic agent, which is known to battle 
cancer but challenging due to its hydrophilic nature. Nanoemulsion is water-in-oil (W/O) 
nanoemulsion shows potential as a carrier system in delivering gemcitabine to the cancer cell. 
Methods: The behaviour of GEM in MCT/surfactants/NaCl systems was studied in the 
ternary system at different ratios of Tween 80 and Span 80. The system with surfactant ratio 
3:7 of Tween 80 and Span 80 was chosen for further study on the preparation of 
nanoemulsion formulation due to the highest isotropic region. Based on the selected ternary 
phase diagram, a composition of F1 was chosen and used for optimization by using the D-
optimal mixture design. The interaction variables between medium chain triglyceride (MCT), 
surfactant mixture Tween 80: Span 80 (ratio 3:7), 0.9 % sodium chloride solution and 
gemcitabine were evaluated towards particle size as a response. 
Results: The results showed that NaCl solution and GEM gave more effects on particle size, 
polydispersity index and zeta potential of 141.57±0.05 nm, 0.168 and −37.10 mV, 
respectively. The optimized nanoemulsion showed good stability (no phase separation) 
against centrifugation test and storage at three different temperatures. The in vitro release of 
gemcitabine at different pH buffer solution was evaluated. The results showed the release of 
GEM in buffer pH 6.5 (45.19%) was higher than GEM in buffer pH 7.4 (13.62%). The 
cytotoxicity study showed that the optimized nanoemulsion containing GEM induced 
cytotoxicity towards A549 cell and at the same time reduced cytotoxicity towards MRC5 
when compared to the control (GEM solution). 
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